IL17A and neoplasm: Early barrier loss and activation of IL23/IL17-driven tumour-elicited inflammation act additively and sequentially to genetically controlled events that govern CRC development and progression in ApcF/WTmiceIFNgamma and TNFalfa alter barrier properties of the intestinal epithelium increasing epithelial paracellular permeability human in cell lines